Immunotherapy Special Issue 2020

Patients can pick from a growing array of treatments, from same-day- results surgery to game-changing immunotherapy, to fight the most common type of cancer.

Across cancer types, a unique immune-stimulating treatment called tumor-infiltrating lymphocyte therapy produces durable remissions that could last for decades.

New immunotherapy combinations aim to turbocharge the immune system’s attack against cancer.